Cardiologist passionate about research

Joined September 2018
91 Photos and videos
Pinned Tweet
Female power United in Prevention! Listen to the great ideas the presidents of the ESC Associations have shared in an amazing session at #ESCPrev2025 #escprevmotions @EAPCPresident @denisamuraru @PTBuketAkinci @AnastasiaSMihai
1
13
36
12,607
Svetlana Mosteoru retweeted
Young adults who simultaneously have borderline high blood pressure, blood sugar, and cholesterol levels face a significantly higher long-term risk of heart attack and stroke, even though they are often considered ‘low risk' 👉doi.org/10.1093/eurjpc/zwag2…
1
13
19
986
Svetlana Mosteoru retweeted
ANGPTL3 inhibition offers broad lipid-lowering benefits, with particularly marked reductions in TG-rich lipoproteins 👉doi.org/10.1093/eurjpc/zwag2… @escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic
14
22
1,004
Svetlana Mosteoru retweeted
Oral PCSK9 inhibitors 💊 demonstrate potent LDL-C–lowering efficacy, comparable to parenteral PCSK9i, with favourable effects on other atherogenic lipids 👉doi.org/10.1093/eurjpc/zwag2… @escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic
10
18
605
Svetlana Mosteoru retweeted
🧪 Target Trial Emulation (TTE) is reshaping cardiovascular real-world evidence. By designing observational studies to mimic hypothetical RCTs, TTE helps reduce avoidable bias and strengthen causal interpretation in clinical research. 🫀📊ow.ly/ex4L50Z5UHy #EJPC @EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @SMosteoru @TimKambic
22
40
7,194
Svetlana Mosteoru retweeted
Even before diabetes develops, dysglycaemia may increase AF risk. ⚠️ A meta-analysis including 26.4 million participants showed that prediabetes was associated with ⬆️15% risk of AF, supporting a dose–response relationship across glucose levels. 🔗doi.org/10.1093/eurjpc/zwag2…
25
61
9,930
Exercise may reduce risk of ASCVD by 50%, but is not a substitute for established medical therapy! #EASCongress2026 @MichaelPapadak2
2
4
23
3,778
Svetlana Mosteoru retweeted
🏃‍♂️ More than 1 in 3 athletes show elevated cardiac troponin levels after exercise. This meta-analysis highlights that elevations are most common after endurance events lasting 3–6 h and with high-sensitivity cTnT assays.🫀 🔗doi.org/10.1093/eurjpc/zwag2… #sportscardiology
10
38
1,882
Transatlantic dyslipidemia guidelines recommendations! #EASCongress2026
4
11
635
Svetlana Mosteoru retweeted
Great science matters — but so do the people, collaborations, and conversations that make the EAS community special. Who are you excited to see at #EASCongress2026? #EAS2026 #RoadToEASCongress2026
2
12
306
Plasma Lp(a) concentrations predict incident aortic stenosis and progression #EASCongress2026
2
12
230
Svetlana Mosteoru retweeted
New in #EJPC: Cuffless Blood Pressure Monitoring Devices: Technical Foundations and Clinical Implications: Scientific Statement of the European Society of Cardiology (ESC) Working Group on e-Cardiology, the ESC Council on Hypertension, and the European Association of Preventive Cardiology of the ESC ow.ly/SQ1H50Z3CQK @EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @SMosteoru @TimKambic
14
23
3,184
The genetic paradox #EASCongress2026
3
12
1,056
Should we move from the dichotomy of primary and secondary prevention? Check out the results of the Vesalius trial #EASCongress2026
2
6
281
Svetlana Mosteoru retweeted
We’re kicking off the #EASCongress2026 Scavenger Hunt with the first hint! Find a first envelope and win a special experience in Gothenburg, Sweden - the host city of EAS Congress 2027. 🔗 Find out more about the scavenger hunt: bit.ly/4wr1dnr #Atherosclerosis
2
12
918
EAS has already started ... Who is at Risk of Cardiovascular Events? Join this amazing session now! #EAS2026 #EASCongress2026 #MyEAS2026
1
5
243
Svetlana Mosteoru retweeted
Sunday morning congress prep: download the #EASCongress2026 app before the first sessions start Your future self, trying to be in three places at once, will thank you :) 🔗eas-congress.com/2026/congre… @EASCongress @society_eas #EASSoMe #MyEAS2026
4
13
310
Svetlana Mosteoru retweeted
Resistant hypertension remains a high-risk condition but lower BP targets may help. The STEP trial analysis found intensive BP control (<130 mmHg) was associated with substantially fewer cardiovascular events (64% ⬇️), without added safety concerns. doi.org/10.1093/eurjpc/zwaf5…
1
10
22
1,359
Svetlana Mosteoru retweeted
New from the Hordaland Health Study: elevated BP in early midlife was linked to greater arterial stiffness 27 years later in women but not in men. A powerful signal for earlier and sex-specific cardiovascular prevention. 🫀♀️ doi.org/10.1093/eurjpc/zwaf3…
2
6
17
670